3’UTR Polymorphism in ACSL1 Gene Correlates with Expression Levels and Poor Clinical Outcome in Colon Cancer Patients

• Teodoro Vargas,

  Affiliation Molecular Oncology, IMDEA-Food Institute, CEI UAM+CSIC, Madrid, Spain

  ⨯
• Juan Moreno-Rubio,

  Affiliations Molecular Oncology, IMDEA-Food Institute, CEI UAM+CSIC, Madrid, Spain, Precision Oncology Laboratory (POL), Infanta Sofía University Hospital, San Sebastián de los Reyes, Madrid, Spain, Translational Oncology Laboratory, La Paz University Hospital (IdiPAZ), Madrid, Spain

  ⨯
• Jesús Herranz,

  Affiliation Biostatistics and Bioinformatics Unit, IMDEA-Food Institute, CEI UAM+CSIC, Madrid, Spain

  ⨯
• Paloma Cejas,

  Affiliations Translational Oncology Laboratory, La Paz University Hospital (IdiPAZ), Madrid, Spain, Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA, United States of America

  ⨯
• Susana Molina,

  Affiliation Molecular Oncology, IMDEA-Food Institute, CEI UAM+CSIC, Madrid, Spain

  ⨯
• Marta Mendiola,

  Affiliation Translational Oncology Laboratory, La Paz University Hospital (IdiPAZ), Madrid, Spain

  ⨯
• Emilio Burgos,

  Affiliation Pathology Department, La Paz University Hospital (IdiPAZ), Madrid, Spain

  ⨯
• Ana B. Custodio,

  Affiliation Medical Oncology, La Paz University Hospital (IdiPAZ), Madrid, Spain

  ⨯
• María De Miguel,

  Affiliation Translational Oncology Laboratory, La Paz University Hospital (IdiPAZ), Madrid, Spain

  ⨯
• Roberto Martín-Hernández,

  Affiliation Biostatistics and Bioinformatics Unit, IMDEA-Food Institute, CEI UAM+CSIC, Madrid, Spain

  ⨯
• Guillermo Reglero,

  Affiliation Molecular Oncology, IMDEA-Food Institute, CEI UAM+CSIC, Madrid, Spain

  ⨯
• Jaime Feliu,

  Affiliation Medical Oncology, La Paz University Hospital (IdiPAZ), Madrid, Spain

  ⨯
• Ana Ramírez de Molina

  * E-mail: ana.ramirez@imdea.org

  Affiliation Molecular Oncology, IMDEA-Food Institute, CEI UAM+CSIC, Madrid, Spain

  ⨯